Literature DB >> 26129735

Soluble vascular endothelial-cadherin and auto-antibodies to human vascular endothelial-cadherin in human diseases: Two new biomarkers of endothelial dysfunction.

Sophie Blaise1, Helena Polena2, Isabelle Vilgrain2.   

Abstract

Vascular endothelial-cadherin is the most important transmembrane component of endothelial adherens junctions, exclusively expressed by endothelial cells in all types of vessels. Targeting either the extracellular domain or the cytoplasmic tail deleteriously affects the junctional strength and leads to vascular permeability. Recently, cytokine-induced phosphorylation of the vascular endothelial-cadherin cytoplasmic domain was reported to trigger cleavage of its extracellular domain, producing the soluble form of the protein - soluble vascular endothelial-cadherin. Hence, the presence of soluble vascular endothelial-cadherin or auto-antibodies to human vascular endothelial-cadherin in human serum could signalize the presence of vascular abnormalities. This systematic review covers many human studies reporting increased levels of soluble vascular endothelial-cadherin, as well as auto-antibodies to human vascular endothelial-cadherin, which could be promising biomarkers of endothelial dysfunction in a large panel of diseases.
© The Author(s) 2015.

Entities:  

Keywords:  atherosclerosis; autoimmune disease; biomarkers; cancer; endothelial dysfunction; inflammation; sepsis

Mesh:

Substances:

Year:  2015        PMID: 26129735     DOI: 10.1177/1358863X15591201

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  5 in total

1.  Renal cell markers: lighthouses for managing renal diseases.

Authors:  Shivangi Agarwal; Yashwanth R Sudhini; Onur K Polat; Jochen Reiser; Mehmet M Altintas
Journal:  Am J Physiol Renal Physiol       Date:  2021-10-11

2.  Serum expression of Vascular Endothelial-Cadherin, CD44, Human High mobility group B1, Kallikrein 6 proteins in different stages of laryngeal intraepithelial lesions and early glottis cancer.

Authors:  Michał Żurek; Anna Rzepakowska; Iwona Kotuła; Urszula Demkow; Kazimierz Niemczyk
Journal:  PeerJ       Date:  2022-04-19       Impact factor: 3.061

3.  Adenosine-to-Inosine Editing of Vasoactive MicroRNAs Alters Their Targetome and Function in Ischemia.

Authors:  Reginald V C T van der Kwast; Laura Parma; M Leontien van der Bent; Eva van Ingen; Fabiana Baganha; Hendrika A B Peters; Eveline A C Goossens; Karin H Simons; Meindert Palmen; Margreet R de Vries; Paul H A Quax; A Yaël Nossent
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-21       Impact factor: 8.886

4.  Quantification of Lipoteichoic Acid in Hemodialysis Patients With Central Venous Catheters.

Authors:  Amy Barton Pai; Adinoyi Garba; Paul Neumann; Alexander J Prokopienko; Gabrielle Costello; Michael C Dean; Sriram Narsipur
Journal:  Front Med (Lausanne)       Date:  2018-11-05

5.  Exposure to Zinc Oxide Nanoparticles Disrupts Endothelial Tight and Adherens Junctions and Induces Pulmonary Inflammatory Cell Infiltration.

Authors:  Chen-Mei Chen; Meng-Ling Wu; Yen-Chun Ho; Pei-Yu Gung; Ming-Hsien Tsai; Alexander N Orekhov; Igor A Sobenin; Pinpin Lin; Shaw-Fang Yet
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.